CellCarta laboratories are accredited by the College of American Pathologists (CAP) and hold CLIA certificates of accreditation across our global facilities. These accreditations ensure that our central lab services meet the highest standards for late phase clinical trial data.
","btn_text":"Learn about our standards","btn_url":"https://cellcarta.com/clinical-trial-services/regulatory-services/cap-clia-iso-accreditations/","btn_target":"_self","bullets":""},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Quality-Management-System-Hero-748.jpg","image_alt":"","title":"Data Integrity & Security ","desc":"Our data systems are 21 CFR Part 11-compliant and are covered by ISO 27001 Information Security Management accreditation across all major locations,protecting your clinical data at every stage. ","btn_text":"Explore data security","btn_url":"/clinical-trial-services/regulatory-services/laboratory-quality-management-system/","btn_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Sample-Logistics-401.jpg","image_alt":"","title":"Sample Logistics","desc":"End-to-end sample logistics spanning custom kitting,cold-chain shipping,PBMC processing,and biorepository storage,managed through our ISO 13485-certified logistics facilities.
","btn_text":"View sample logistics","btn_url":"/clinical-trial-services/sample-logistics/","btn_target":"_self","bullets":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit.
Nulla consequat massa quis enim.
Aenean commodo ligula eget dolor.
Cum sociis natoque penatibus et magnis dis.
\nNulla consequat massa quis enim.
"}];oxy-supreme-core-solutions-header-width:default}#-supreme-cellcarta-faq-10-168{items-data:[{"faq_question":"What is a central lab,and why does it matter in late phase trials? ","faq_answer":"A central lab is a single,accredited laboratory partner that performs all clinical assays for a trial,replacing site-by-site testing to ensure consistency,quality,and traceability. In late phase trials,central lab support matters because data volume,regulatory scrutiny,and multi-region enrolment make reproducibility and audit-readiness non-negotiable. Harmonized standard operating procedures,common reagents and controls,and integrated data systems remove variability that could compromise submission.
CellCarta operates CAP-accredited,CLIA-certified central labs in Belgium,USA,Canada,and China.
Samples in global late phase trials are managed through integrated logistics covering site kit design and distribution,validated cold-chain and ambient shipping,PBMC isolation and cryopreservation,biorepository storage with full chain-of-custody,and harmonized processing standard operating procedures across regions.
\nLogistics quality systems aligned with ISO 13485 underpin reliable performance at scale. Logistics failures are a leading cause of late phase data loss and timeline slippage. CellCarta operates ISO 13485-certified logistics facilities,supporting global trial networks.
"},{"faq_question":"How is data integrity and audit-readiness ensured across multi-region late phase trials?","faq_answer":"Data integrity in late phase trials depends on validated data systems aligned with 21 CFR Part 11,harmonized standard operating procedures across regional labs,information security management aligned with ISO 27001,and a documented audit trail spanning sample chain-of-custody through final data delivery.
\nCross-site bridging studies,standardized reagents and controls,and routine quality monitoring confirm reproducibility. CellCarta's late phase infrastructure includes 21 CFR Part 11-compliant data systems,ISO 27001-compliant information security across major locations,and harmonized quality systems across 8 global facilities.
"},{"faq_question":"What quality standards and accreditations should a late phase central lab partner hold?","faq_answer":"A late phase clinical trial laboratory should hold accreditations recognized by major regulators,typically CAP and CLIA for clinical assay reporting in the US,and equivalents such as ISO 15189 internationally. Data systems should be aligned with 21 CFR Part 11. Information security should follow ISO 27001 standards. Logistics facilities should be ISO 13485-certified. Multi-site harmonization and demonstrated cross-lab reproducibility are equally important.
\nCellCarta's global facilities are CAP-accredited and CLIA-certified across Belgium,USA,Canada,and China,with ISO 27001 and ISO 13485 coverage.
"},{"faq_question":"How do biomarker and companion diagnostic strategies evolve from early to late phase? ","faq_answer":"Biomarker and CDx strategies tighten significantly moving into late phase. Exploratory biomarkers must be qualified or formally validated for their intended use,fit-for-purpose assays must be locked to support primary or key secondary endpoints,and companion diagnostic candidates must complete analytical and clinical validation in time for regulatory submission.
\nMulti-region harmonization,regulatory alignment,and bridging across earlier-phase assay versions become critical. CellCarta supports the full lifecycle,including CDx strategy,assay development,and regulatory-grade validation.
"}]}#-supreme-cellcarta-featured-resources-8-168{cards-data:[{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-2.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-3.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"}]}#-supreme-cellcarta-how-it-works-12-168{steps-data:[{"step_label":"Step 01","title":"Study design","description":"Biomarker strategy and protocol planning for your endpoints. "},{"step_label":"Step 02","title":"Protocol alignment","description":"Global regulatory alignment built in from the start."},{"step_label":"Step 03","title":"Sample logistics","description":"Sample kitting,shipping,and processing across all sites."},{"step_label":"Step 04","title":"Assay execution","description":"Validated assays run in accredited central labs globally."},{"step_label":"Step 05","title":"Data delivery","description":"Clean,audit-ready data packages delivered on schedule."},{"step_label":"Step 06","title":"Regulatory support ","description":"Expert guidance on submissions across FDA,EMA,and NMPA."}]}#-supreme-cellcarta-overview-4-168{stats-data:[{"number":"25+ ","label":"Years of expertise "},{"number":"2,700+ ","label":"Clinical trials supported "},{"number":"8 ","label":"Global facilities"}]}#-supreme-cellcarta-service-blocks-14-168{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/08/CellCarta_-47-2-1-crop-to-models-scaled.jpg","image_alt":"","title":"CDx Development ","description":"From prototype assay to IVD and CDx — development,validation,and submission support.","button_text":"Explore CDx development","button_url":"/clinical-trial-services/cdx-development","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/08/CellCarta-884-scaled.jpg","image_alt":"","title":"Regulatory Services ","description":"Navigate global regulatory requirements with expert guidance and submission support. ","button_text":"Explore regulatory services","button_url":"/clinical-trial-services/regulatory-services/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Sample-Logistics-Hero-404.jpg","image_alt":"","title":"Sample Logistics ","description":"Global sample management,transport,and biorepository services. ","button_text":"Explore sample logistics","button_url":"/clinical-trial-services/sample-logistics/","button_target":"_self"}]}#-supreme-cellcarta-testimonials-7-168{items-data:[{"quote":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes,nascetur ridiculus mus. Donec quam felis,ultricies nec,pellentesque eu,pretium quis,sem. Nulla consequat massa quis enim. Donec pede justo,\u00a0","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"},{"quote":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit.","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"},{"quote":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit.","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"}]}